Evidence map›Paper›PMID 40281285›Full record

ArticleScientific reports2025

Translational immune and metabolic markers of aging in dogs.

James E McMahon, Jessica L Graves, Ashley P Tovar, Matthew Peloquin, Karen Greenwood, Frances L Chen, Michelle Nelson, Erin E McCandless, Celine-Lea Halioua-Haubold, Dina Juarez-Salinas

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James E McMahonCellular Longevity Inc., San Francisco, CA, USA. james.mcmahon@loyal.com.
Jessica L GravesCellular Longevity Inc., San Francisco, CA, USA.
Ashley P TovarCellular Longevity Inc., San Francisco, CA, USA.
Matthew PeloquinCellular Longevity Inc., San Francisco, CA, USA.
Karen GreenwoodCellular Longevity Inc., San Francisco, CA, USA.
Frances L ChenCellular Longevity Inc., San Francisco, CA, USA.
Michelle NelsonCellular Longevity Inc., San Francisco, CA, USA.
Erin E McCandlessCellular Longevity Inc., San Francisco, CA, USA.
Celine-Lea Halioua-HauboldCellular Longevity Inc., San Francisco, CA, USA.
Dina Juarez-SalinasCellular Longevity Inc., San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dogs serve as a promising aging model due to their genetic diversity, condensed lifespan, and shared living environment with humans. Alterations in the immune and metabolic parameters are hallmarks of aging in humans, but few studies have investigated these changes in dogs. We investigated the association of whole blood parameters with aging in a cross-sectional field study with a population of 451 companion dogs. Additionally, we measured total lymphocytes, total T-cells, CD4 T-cells, CD8 T-cells, B-cells, CBC, insulin and adiponectin in a cross-sectional study of 74 laboratory research beagles. In companion dogs, we report total lymphocytes and RBCs decrease significantly with age while platelets increase significantly. In lab beagles, total lymphocytes, T-cells, CD4 T-cells, CD8 T-cells, and B cells are significantly lower in Aged and Geriatric beagles. Furthermore, the CD4/CD8 ratio is significantly lower in Geriatric beagles. We also found that Geriatric beagles experience hyperinsulinemia, while plasma adiponectin is significantly lower in both Aged and Geriatric beagles. These results align with the age-related immune and metabolic alterations seen in humans and provide additional evidence that dogs serve as a relevant translational model of aging.

Indexed as

AgingBiomarkersAdiponectinAnimalsB-LymphocytesCD4-CD8 RatioCD8-Positive T-LymphocytesCross-Sectional StudiesDogsFemaleInsulinMaleAdiponectinBiomarkersInsulin

Identifiers

PMID40281285
PMCPMC12032292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.